Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- Metastatic Fallopian Tube Carcinoma
- Metastatic Ovarian Carcinoma
- Metastatic Primary Peritoneal Carcinoma
- Ovarian Endometrioid Tumor
- Ovarian High Grade Serous Adenocarcinoma
- Platinum-Sensitive Ovarian Carcinoma
- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Primary Peritoneal Carcinoma
- Stage IV Fallopian Tube Cancer AJCC v6 and v7
- Stage IV Ovarian Cancer AJCC v6 and v7
- Stage IV Primary Peritoneal Cancer AJCC v7
Interventions
- DRUG: Berzosertib
- DRUG: Carboplatin
- DRUG: Gemcitabine Hydrochloride
- OTHER: Laboratory Biomarker Analysis
- OTHER: Pharmacological Study
Sponsor
National Cancer Institute (NCI)